These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Lipodystrophies in non-insulin-dependent children: Treatment options and results from recombinant human leptin therapy. Calcaterra V; Magenes VC; Rossi V; Fabiano V; Mameli C; Zuccotti G Pharmacol Res; 2023 Jan; 187():106629. PubMed ID: 36566927 [TBL] [Abstract][Full Text] [Related]
29. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice. Abulizi A; Perry RJ; Camporez JPG; Jurczak MJ; Petersen KF; Aspichueta P; Shulman GI FASEB J; 2017 Jul; 31(7):2916-2924. PubMed ID: 28330852 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study. Guidorizzi NR; Valerio CM; Viola LF; Veras VR; Fernandes VO; Lima GEDCP; Flor AC; Araújo JS; Gonçalves Muniz RB; Moreira RO; De Paula FJA; Zajdenverg L; Dantas JR; Godoy-Matos AF; Montenegro Júnior RM; Foss-Freitas MC Front Endocrinol (Lausanne); 2024; 15():1359211. PubMed ID: 38887266 [TBL] [Abstract][Full Text] [Related]
31. A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities. Ozgen Saydam B; Sonmez M; Simsir IY; Erturk MS; Kulaksizoglu M; Arkan T; Hekimsoy Z; Cavdar U; Akinci G; Demir T; Altay CT; Mihci E; Secil M; Akinci B Endocr Res; 2019; 44(1-2):46-54. PubMed ID: 30182761 [TBL] [Abstract][Full Text] [Related]
32. Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study. Oral EA; Garg A; Tami J; Huang EA; O'Dea LSL; Schmidt H; Tiulpakov A; Mertens A; Alexander VJ; Watts L; Hurh E; Witztum JL; Geary RS; Tsimikas S J Clin Lipidol; 2022; 16(6):833-849. PubMed ID: 36402670 [TBL] [Abstract][Full Text] [Related]
33. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Araujo-Vilar D; Sánchez-Iglesias S; Guillín-Amarelle C; Castro A; Lage M; Pazos M; Rial JM; Blasco J; Guillén-Navarro E; Domingo-Jiménez R; del Campo MR; González-Méndez B; Casanueva FF Endocrine; 2015 May; 49(1):139-47. PubMed ID: 25367549 [TBL] [Abstract][Full Text] [Related]
34. Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins). Mosbah H; Donadille B; Vatier C; Janmaat S; Atlan M; Badens C; Barat P; Béliard S; Beltrand J; Ben Yaou R; Bismuth E; Boccara F; Cariou B; Chaouat M; Charriot G; Christin-Maitre S; De Kerdanet M; Delemer B; Disse E; Dubois N; Eymard B; Fève B; Lascols O; Mathurin P; Nobécourt E; Poujol-Robert A; Prevost G; Richard P; Sellam J; Tauveron I; Treboz D; Vergès B; Vermot-Desroches V; Wahbi K; Jéru I; Vantyghem MC; Vigouroux C Orphanet J Rare Dis; 2022 Apr; 17(Suppl 1):170. PubMed ID: 35440056 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia. D'Erasmo L; Gallo A; Di Costanzo A; Bruckert E; Arca M Expert Opin Pharmacother; 2020 Oct; 21(14):1675-1684. PubMed ID: 32646313 [TBL] [Abstract][Full Text] [Related]
36. Hypertriglyceridemia. Chait A Endocrinol Metab Clin North Am; 2022 Sep; 51(3):539-555. PubMed ID: 35963627 [TBL] [Abstract][Full Text] [Related]
37. Lipodystrophy: lessons in lipid and energy metabolism. Simha V; Garg A Curr Opin Lipidol; 2006 Apr; 17(2):162-9. PubMed ID: 16531753 [TBL] [Abstract][Full Text] [Related]